Clinical Trial

Comprehensive Geriatric Assessment in Chronic Disease Management for Older Adults in China: A Registry Study (CGACDM - Older Adults in China)

Study acronym: CGACDM - Older
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
With the continuous development of China's economy and the improvement of medical standards, the life expectancy of the Chinese population has significantly increased. Against the backdrop of accelerating aging in China, the incidence of age-related chronic non-communicable diseases (NCDs), such as cardiovascular and cerebrovascular diseases and chronic respiratory diseases, has risen remarkably. These diseases are characterized by multiple comorbidities, high disability rates, and high mortality rates, severely compromising the quality of life of older adults, exacerbating family burdens, and straining healthcare systems. This constitutes one of the major challenges faced by aging societies. Therefore, early detection and intervention of chronic diseases in older adults are critical measures to address population aging. Comprehensive geriatric assessment (CGA), a core specialty of geriatric medicine, serves as a fundamental framework for the clinical identification of geriatric syndromes and multidisciplinary management. It is emerging as a key pathway to promote "healthy aging." Guided by this premise, this study aims to explore the application value of CGA in managing chronic diseases among older adults, with the goal of achieving full-cycle management for early detection, diagnosis, and treatment of chronic conditions in China's elderly population.
Trial Details
NCT Number NCT07033871
Lead Sponsor Henan Provincial People's Hospital
Collaborators: Geriatrics Research Institute of Henan Provincial People's Hospital, Beijing Institute of Heart, Lung and Blood Vessel Diseases
Conditions Comprehensive Geriatric Assessment, Chronic Disease Management, Older Adults (65 Years and Older)
Enrollment 1,000 participants
Start Date 2025-07-01
Primary Completion 2030-05-01 (estimated)
Study Completion 2030-05-01 (estimated)
Updated on ClinicalTrials.gov 2025-06-24